Plakoglobin (γ-catenin) and β-catenin are pivotal components of cell-cell adherent junctions that link cadherin receptors to the actin cytoskeleton. While β-catenin over-expression induces cell proliferation and tumor formation, plakoglobin has tumor suppressor activity. We investigated the expression of plakoglobin in alveolar (ARMS) and embryonal (ERMS) rhabdomyosarcoma (RMS) cell lines and tumors, and found that plakoglobin is present both in the cytoplasm and in the nucleus of ERMS cells, whereas it is absent or detectable at extremely low levels in ARMS. Because gene silencing can be mediated by methylation and/or deacetylation of promoter regions, we assessed the effects of the DNA demethylating 
INTRODUCTION
Rhabdomyosarcoma (RMS) includes two major histological subtypes: the more frequent embryonal RMS (ERMS), and the more aggressive alveolar RMS (ARMS) (1, 2) . The latter harbors a reciprocal chromosomal translocation t(2;13)(q35;q14) or, less frequently, the variant translocation t(1;13)(p36;q14) (3, 4) that generate a powerful chimeric transcriptional activator PAX3-FKHR or PAX7-FKHR (5) with oncogenic activity (6) . The PAX3-FKHR fusion protein causes aberrant expression of a set of PAX3-target genes normally regulated during development by the wild-type protein, including c-Met (7, 8) or the HER/erbB family members (EGFR and erbB2) (9) , which have been closely linked with tumor aggressiveness and poor prognosis in many cancer types. These receptor tyrosine kinases, which are expressed in RMS cell lines (7) (8) (9) , are involved in proliferation, migration and metastasis through the phosphorylation of different proteins contained in cellular junctions with consequent tissue destruction and increase of invasiveness.
β-catenin is a multifunctional protein that plays a pivotal role both in cell-cell interactions and transcriptional activation in Wnt/Wingless signalling during development (10) . The regulation of membrane, cytoplasmic and nuclear pools of β-catenin is crucial for modulating its adhesion and signalling functions (11) .
The catenin family member plakoglobin, also known as γ-catenin, is an adhesion molecule with structure, cellular distribution and protein-binding specificity similar to β-catenin. In addition to its involvement in the desmosome structure, plakoglobin is a component of the adherens junctions and binds E-cadherin and α-catenin (12).
β-catenin expression level is high in cancers of various origin (13) , mostly as a result of point mutations in β-catenin phosphorylation sites necessary for its ubiquitination or in key components of the degradation machinery (14, 15) . Unlike β-catenin, plakoglobin mutations are rare. However, the human plakoglobin gene can display loss of heterozygosity in certain tumors and this has been associated to cancer progression (16) . Moreover, plakoglobin overexpression was shown to suppress tumorigenicity in various transformed cell lines (17) .
Methylation of cytosine residues at CpG dinucleotides repeats is an important biological phenomenon for gene silencing and regulation of chromatin structure. Cytosine hypermethylation in the promoters of tumor suppressor genes such as RASSF1A and HC1 has been linked to transcriptional repression (18, 19) . Recent work has demonstrated the importance of post-translational modification of histone proteins as another epigenetic mechanism in the organization of chromosomal domains and gene regulation (20, 21) .
Acetylation of lysine residues on histone H3 and H4 leads to formation of open chromatin structure (22) , whereas deacetylation is associated with repressed chromatin (20, 23) . There is growing evidence that an interplay exists between cytosine methylation and histone modification. The methyl-CpG binding protein, MeCP2, has been associated with histone deacetylase (HDAC) activity, suggesting that histone modification can be induced by DNA methylation changes (24, 25) .
In this study we report that plakoglobin was down-regulated in a subset of RMS and hypothesized that this may be a consequence of hypermethylation of CpG islands and hypoacetylation of histones within plakoglobin promoter region. To test these hypotheses, the expression and the methylation/acetylation status of the plakoglobin promoter were analyzed in RMS cell lines and biopsies. 6 Chemiluminescent Substrate (Pierce). Membranes were exposed to Hyperfilm (Amersham) and signals were quantified by using the NIH Image analysis software.
Semi-quantitative RT-PCR Analysis. Total RNA was extracted from cultured cells and tumor specimens using RNAzol-Bee reagent (Tel-Test, Friendswood, TX) according to the manufacturer's instructions. One microgram of total RNA from each sample was reverse transcribed by using the Superscript II Reverse Transcriptase (Invitrogen Corp., Carlsbad, CA) and random hexamers. The cDNAs were then amplified by PCR using primers specific for plakoglobin (5'-ATGGAGGTGATGAACCTGATGG-3' and 5'-TGGCATAGAACAGGACCGACTC-3') and for β2-microglobulin, used as an internal control to standardize the amount of DNA in each sample, (5'-GTGGAGCATTCAGACTTGTCTTTCAGCA-3' and 5'-TTCATCCAATCCAAATGCGGCATCTTC-3'). Based on preliminary experiments we identified the PCR exponential phase and selected 33 cycles for amplification of plakoglobin and 26 cycles for β2-microglobulin.
PCR conditions included initial denaturation at 94°C for 2 min followed by 94°C for 45s, 61°C for 30s, 72°C for 45s, for plakoglobin, and by 94°C for 15s, 60°C for 15s, 72°C for 15s, for β2-microglobulin, and a final extension step at 72°C for 5 min, on a GeneAmp PCR 9600 System (ABI Applied Biosystems, Foster City, CA).
PCR products were electrophoresed through 2% agarose gels and quantified by densitometric analysis of band intensity using Quantity One Quantitation Software (Bio-Rad, Milan, Italy).
Nuclear and Cytoplasmic Protein Fractions.
To obtain purified cytoplasmic and nuclear fractions, cells were processed according to the protocol described by (26) . Cells grown on Petri dishes were washed 3 times in icecold 1X PBS, frozen on dry ice and scraped into hypotonic lysis buffer [10mM Hepes, 10mM KCl, 0.2mM EDTA, 0.1mM EGTA, 1mM DTT and a cocktail of protease inhibitors] with 2% NP-40. Cell lysates were incubated on ice for 10min, passed through a 18 gauge needle and then centrifuged for 2 min at 10000 g. The supernatant was removed as cytoplasmic fraction and the pellets were resuspended in hypertonic buffer [20mM Hepes, 0.4M NaCl, 1mM EDTA, 1mM DTT and a cocktail of protease inhibitors] and triturated with a pestle.
The nuclei were incubated for 30min on ice and then microcentrifuged at 4°C for 5min at 10000 g. The supernatant containing nuclear extract was collected and aliquoted.
Analysis of plakoglobin Gene Hypermethylation by MSP and Bisulfite DNA Sequencing. The plakoglobin gene methylation was studied by methylation-specific PCR assay as previously reported (27) . Briefly, genomic DNA was isolated using a commercial kit (Qiagen, Hilden, Germany) and bisulfite modification was obtained using CpGenome TM DNA Modification Kit (Chemicon International, Temecula, CA). The modified DNA was subjected to PCR in separate reactions using the primers pairs specific for the methylated sequence, PG-M (5'-TAGTCGTCGTTCGATCGCGTC-3' and 5'-AACCGAATCGAAATCGAACCG-3'), and for the unmethylated sequence, PG-U (5'-TTGGAGTAGTTGTTGTTTGATTGTGTT-3' and 5'-CAAACCAAATCAAAATCAAACCAA-3') as previously described [28] Bisulfite-modified DNA was amplified using Pan-S (5'-GGTTTGGTTGTTAGGTTTTT-3') and Pan-AS (5'-CACTCAATCACCTTAATAAACTACTCC-3') primers. This primer set does not cover any CpG sites within the primer sequences, as previously reported (39) . PCR products obtained, were amplified by a second round of nested PCR using primers BD-S (5'-TTGAGTTGTTGTTTTGGTTAGAGTT-3') and BD-AS (5'-TAACTACTAAATATAAAACCTAACC-3') (39) . PCR products were then sequenced using the ABI PRISM 377 DNA sequencer (Applied Biosystems) using BD-S and BD-AS primers.
ChIP analysis. Cells grown in 100mm dishes were treated with or without TSA (200ng/ml) for 16h. Before harvesting, the cells were treated with 1% formaldehyde for 10 min at room temperature to crosslink histones to DNA. Crosslinking was quenched by addition of glycine at a final concentration of 0.125M and 5min incubation at room temperature. Cells were scraped with ice-cold PBS containing 0.5 mM phenylmethylsulfonyl fluoride (PMSF) and centrifuged for 10 min at 720x g a 4°C. ChIP assay was performed using ChIP Assay Kit (Active Motif, CA), according to the manufacturer's instructions. Briefly, the chromatin solutions were sonicated to reduce the DNA length to 200-1000 base pairs, precleared with a salmon sperm DNA/ protein A agarose slurry, and then immunocaptured using antiacetyl-H4 antibody (Upstate) overnight at 4°C with gentle rotation. Aliquots detected in both compartments, was mostly localized in the cytoplasmic fraction. As expected, we were unable to detect plakoglobin both in the cytoplasm and in the nucleus of the ARMS cell lines RH4, RH28, RH30 (Fig. 1D) . and RH18, and ERMS RD cells were treated with 5AzadC and TSA alone or in combination, and plakoglobin gene expression was assessed at both mRNA and protein levels. As shown in To assess the methylation status in more detail, a promoter region of plakoglobin gene that allows the study of 9 CpG islands by direct sequencing was amplified by two-step PCR. As demonstrated by sequence analysis of the amplicons (Fig. 3B) and summarized in Fig. 3C , the RH4 cell line which showed two methylated plakoglobin alleles, was heavily methylated at all 9 CpG sites tested. In contrast, RD cells that harbor only unmethylated alleles (Fig. 3A) , completely lacked methylated CpG sites (Fig. 3B ). RH30 cells showed the presence of both metylated and un-methylated CpG islands. RH18 possessed all of the CpG islands unmethylated except CpG +54 that was methylated. In addition, sequence analysis of cloned PCR products, that allows to study a higher number of CpG islands, showed that CpG island +33, included in the primer sequence used for MSP asssay, was methylated in 1/6 RH18 clones (data not shown).
Restoration of plakoglobin expression in ARMS cells
To investigate histone deacetylation as epigenetic mechanism contributing to gene silencing, Last, we studied 11 RMS tumor biopsies: 4 PAX3-FKHR-positive and 2 PAX3-FKHRnegative ARMS, and 5 ERMS (Fig. 4A) . Results in Fig. 4A -B confirmed that β-catenin was expressed at high levels in all specimens, whereas plakoglobin, detected in all of the ERMS biopsies, was barely detectable in the ARMS biopsies. We investigated the methylation status of the plakoglobin gene promoter in 7 of the 11 biopsies by MSP analysis. The hemimethylated pattern, was predominant irrespective of the histological subtype ( Fig. 4C) with the exception of sample N. 6 (ARMS) that showed a higher signal intensity for the methylated allele and sample N. 8 (ERMS) where the un-methylated allele was more evident.
DISCUSSION
Plakoglobin over-expression is known to suppress cell proliferation and tumorigenicity, consistent with its ability to act as a tumor suppressor (17, 33) . Low or absent plakoglobin expression in cancer implies changes in intercellular junctions and may thus predispose to tumor invasion and metastasis. Indeed, down-regulation of plakoglobin is frequently observed in thyroid, lung, and bladder cancer (34) (35) (36) and reduced expression of plakoglobin has been correlated with poor outcome in patients with kidney cancer (37) and neuroblastoma (29) , as well as with poor tumor differentiation and increased lymph node metastases in primary lung cancer (33, 38) . However, the mechanisms that contribute to inactivation of plakoglobin expression in malignant cells have not been fully investigated, although CpG island methylation has been proposed as one of the mechanisms contributing to plakoglobin inhibition in cancer cells (39) .
Our study was designed to determine the expression and cellular localization of catenins in rhabdomyosarcoma cells and to assess whether any relationship exists between the expression of catenins and the RMS histological subtype.
Results demonstrated that plakoglobin is abundantly expressed in embryonal rhabdomyosarcoma (ERMS) cell lines and tumor samples, but is absent or expressed at very low levels in the alveolar subtype (ARMS) that is more aggressive and has a higher tendency to metastasize. In contrast, we found β-catenin consistently expressed at high levels in all RMS cell lines and tumor samples.
Because cytoplasmic accumulation of β-catenin in tumor cells increases its nuclear localization and the transcriptional activity of the Lef-1/Tcf transcription factor family members, causing up-regulation of genes involved in tumor progression and metastasis (40, 41) we determined the sub-cellular distribution of catenins. Plakoglobin and β-catenin localized both in the cytoplasmic and nuclear fractions. This is partly in contrast with a recent paper reporting that catenin expression was restricted to cell membrane and cytoplasm in RMS cells (42) , but may be explained by the different experimental approach used.
Semi-quantitative RT-PCR analysis demonstrated that plakoglobin mRNA was expressed at lower levels in ARMS compared to ERMS cell lines (Fig. 1B-C) , with the exception of RH18 that, originally described as an alveolar RMS cell line lacking both PAX3-FKHR and MyoD1 expression, may likely represent an ERMS cell line (43) Interestingly, the two single agents 5AzadC and TSA had a less pronounced effect on plakoglobin protein expression in RH4 cells that possess both hypermethylated alleles but were highly effective when used in combination, suggesting a marked increase of the acetylation/methylation ratio achieved synergistically by the two agents in a mechanism involving both histone methylation/acetylation status and methylated plakoglobin promoter regions, as previously reported (44) . In contrast, treatment with 5AzadC and/or TSA had only a limited effect on RMS cells that constitutively expressed plakoglobin, such as RD and RH18 cells, independently of the histological subtype.
From further studies based on MSP assay and sequencing, lack of unmethylated allele as in RH4 cells would suggest that gene inactivation might be the consequence of the methylation of both alleles, possibly associated with a deacetylation of histone H4 that may increase plakoglobin gene silencing. However we cannot exclude that presence of one methylated allele and loss of the other may also occur.
The PAX3-FKHR positive RH30 cell line showed loss of plakoglobin expression despite the presence of methylated and unmethylated alleles. DNA sequencing of a promoter region that enabled us to study 9 CpG islands confirmed these findings. In this case we may hypothesize that inactivation of the unmethylated allele might be achieved through different mechanisms such as nonsense or frame-shift mutations, or deletion. In addition we cannot rule out uniparental isodisomy. This is also suggested by the observation that the PAX3-FKHR negative RH18 cell line harboring both unmethylated and methylated alleles does express plakoglobin, although the methylation status of plakoglobin gene promoter region analyzed by sequencing differs from RH30 cells.
The RD cell line did not show either methylation or acetylation of the plakoglobin promoter in agreement with the expression profile.
Finally, in the tumor samples we found both unmethylated and methylated alleles as in some RMS cell lines (Fig 4C and 3A) . 
